Curcumin-loaded lipid nanocarrier for improving bioavailability, stability and cytotoxicity against malignant glioma cells

Drug Delivery

Volumn 23, Issue 1, 2016, Pages 214-229

  Kumar, Anil ^a   Ahuja, Alka ^b   Ali, Javed ^a   Baboota, Sanjula ^a  

^a HAMDARD UNIVERSITY   (India)

^b OMAN MEDICAL COLLEGE   (Oman)

Author keywords

Bioaccessibility; cell line; everted gut sac; in vitro lipolysis study; nanoemulsion

Indexed keywords

CURCUMIN; DIETHYLENE GLYCOL MONOETHYL ETHER; DISTILLED WATER; LIPID; MEDIUM CHAIN TRIACYLGLYCEROL; NANOCARRIER; SOLUTOL HS 15; ANTINEOPLASTIC AGENT; DRUG CARRIER; NANOPARTICLE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CELL VIABILITY ASSAY; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DIGESTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG TRANSPORT; EX VIVO STUDY; GLIOBLASTOMA CELL LINE; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; INTESTINE; INTESTINE ABSORPTION; INTESTINE MUCOSA PERMEABILITY; LIPOLYSIS; LONG TERM CARE; LYMPH VESSEL; MTT ASSAY; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RAT; ZETA POTENTIAL; ANIMAL; BIOAVAILABILITY; BRAIN NEOPLASMS; CHEMISTRY; GLIOBLASTOMA; MEDICINAL CHEMISTRY; TUMOR CELL LINE; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL AVAILABILITY; BRAIN NEOPLASMS; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; CURCUMIN; DRUG CARRIERS; DRUG STABILITY; GLIOBLASTOMA; HUMANS; INTESTINAL ABSORPTION; LIPOLYSIS; NANOPARTICLES; PARTICLE SIZE; RATS; RATS, WISTAR; TRIGLYCERIDES;

EID: 84954316669     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2014.909906     Document Type: Article

References (29)

1. Aggarwal BB, Surh YJ, Shishodia S. (2007). The molecular target and therapeutic uses of curcumin in health and disease. Advances in experimental medicine and biology series, Vol. 595. New York (NY): Springer, 1-66.
2. Amiji MM. (2007). Nanotechnology for cancer therapy. New York (NY): CRC Press. Taylor and Francis, Chapter 35 (723-40).
3. Bartik L, Whitfield GK, Kaczmarska M, et al. (2010). Curcumin: A novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention. J Nutr Biochem 21:1153-61.
4. Cui J, Yu B, Zhao Y, et al. (2009). Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm 371:148-55.
5. Dahan A, Hoffman A. (2007). The effect of different lipid based formulations on the oral absorption of lipophilic drugs: The ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in rats. Eur J Pharm Biopharm 67: 96-105.
6. Das RK, Kasoju N, Bora U. (2010). Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine 6:153-60.
7. Duvoix RB, Delhalle S, Schnekenburger M, et al. (2005). Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223:181-90.
8. Hu L, Jia Y, Niu F, et al. (2012). Preparation and enhancement of oral bioavailability of curcumin using microemulsions vehicle. J Agric Food Chem 60:7137-41.
9. Huang Y, Qiaomei RU. (2010). Bioavailability and delivery of nutraceuticals using nanotechnology. J Food Sci 75:R51-7.
10. Kakkar V, Singh S, Singla D, Kaur IP. (2011). Exploring solid lipid nanoparticles to enhance the oral bioavailability of curcumin. Mol Nutr Food Res 55:495-503.
11. Kashif A, Yan Li, McClements DJ, Xiao H. (2012). Nanoemulsion and emulsion-based delivery systems for curcumin: encapsulation and release properties. Food Chem 132:799-807.
12. Kotta S, Khan AW, Pramod K, et al. (2012). Exploring oral nanoemulsions for bioavailability enhancement of poorly watersoluble drugs. Expert Opin Drug Deliv 9:585-98.
13. Kumar A, Ahuja A, Ali J, Baboota S. (2010). Conundrum and therapeutic potential of curcumin in drug delivery. Crit Rev Ther Drug Carrier Syst 27:279-320.
14. Kumar A, Ahuja A, Ali J, Baboota S. (2012). Curcumin loaded nano globules for solubility Enhancement: preparation, characterization and ex vivo release study. J Nano Nanotech 12:8293-302.
15. Li Y, Hu D, McClements DJ. (2011). Factors affecting lipase digestibility of emulsified lipids using an in vitro digestion model: proposal for a standardised pH-stat method. Food Chem 126:498-505.
16. Li Y, McClements DJ. (2010). New mathematical model for interpreting pH-Stat digestion profiles: impact of lipid droplet characteristics on in vitro digestibility. J Agric Food Chem 58:8085-92.
17. Maiti K, Mukherjee K, Gantait A. (2007). Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 330:155-63.
18. McClements DJ, Decker EA, Park Y. (2009). Controlling lipid bioavailability through physicochemical and structural approaches. Critical Re Food Sci Nut 49:48-67.
19. Onoue S, Takahashi H, Kawabata Y, et al. (2010). Formulation design and photochemical studies on nanocrystal solid dispersion of curcumin with improved oral bioavailability. J Pharm Sci 99: 1871-81.
20. Rao J, McClements MD. (2012). Lemon oil solubilization in mixed surfactant solutions: rationalizing microemulsion & nanoemulsion formation. Food Hydrocolloids 26:268-76.
21. Santos IS, Ponte BM, Boonme P, et al. (2013). Nanoencapsulation of polyphenols for protective effect against colon-rectal cancer. Biotechnol Adv 31:514-23.
22. Singh H, Aiqian Y, David H. (2009). Structuring food emulsions in the gastrointestinal tract to modify lipid digestion. Prog Lipid Res 48: 92-100.
23. Takahashi M, Uechi S, Takara K, et al. (2009). Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. J Agric Food Chem 57: 9141-9.
24. Tonnesen HH, Karlsen J. (1985). Studies on curcumin and curcuminoids. VI. Kinetics of curcumin degradation in aqueous solution. Z Lebensm Unters Forsch 180:402-4.
25. Verma B, Hucl P, Chibbar RN. (2009). Phenolic acid composition and antioxidant capacity of acid and alkali hydrolysed wheat bran fractions. Food Chem 116:947-54.
26. Wennerstrom H, Olsson U. (2009). Microemulsion as model systems. CR Chimie 12:4-17.
27. Williams HD, Anby MU, Sassene PJ, et al. (2012). Toward the establishment of standardized in vitro tests for lipid based formulations, part 2: The effect of bile salt concentration and drug loading on the performance of Type I, II, IIIA, IIIB and IV formulations during in vitro digestion Method parameterization and comparison of in vitro digestion profiles across a range of representative formulations. Mol Pharm 9:3286-300.
28. Zengshuan M, Shayeganpour A, Brocks DR, et al. (2007). Highperformance liquid chromatography analysis of curcumin in rat plasma: application to pharmacokinetics of polymeric micellar formulation of curcumin. Biomed Chromatogr 21:546-52.
29. Zsila F, Bikádi Z, Simonyi M. (2003). Molecular basis of the cotton effects induced by the binding of curcumin to human serum albumin. Tetrahedron Asymmetr 14:2433-44.